APA

Xiao W., Du L., Liang C., Guan J., Jiang S. & Lustigman S. (2008). Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines [PDF]. Netherlands: Elsevier Science B.v.

Chicago

Xiao Wenjun, Du Lanying, Liang Chao, Guan Jie, Jiang Shibo and Lustigman Sara. 2008. Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines [PDF]. Netherlands: Elsevier Science B.v.

Harvard

Xiao W., Du L., Liang C., Guan J., Jiang S. and Lustigman S. (2008). Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines [PDF]. Netherlands: Elsevier Science B.v.

MLA

Xiao Wenjun, Du Lanying, Liang Chao, Guan Jie, Jiang Shibo and Lustigman Sara. Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines [PDF]. Netherlands: Elsevier Science B.v. 2008.